No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib
Crossref DOI link: https://doi.org/10.1007/s00432-016-2321-2
Published Online: 2017-01-12
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pfirrmann, Markus
Evtimova, Dobromira
Saussele, Susanne
Castagnetti, Fausto
Cervantes, Francisco
Janssen, Jeroen
Hoffmann, Verena S.
Gugliotta, Gabriele
Hehlmann, RĂ¼diger
Hochhaus, Andreas
Hasford, Joerg
Baccarani, Michele
License valid from 2017-01-12